Athlete cardiac screening sets out to find the small number of people whose hearts carry a hidden condition that could cause sudden death during sport, and to do so before any harm comes to them. In younger athletes the conditions sought are mainly inherited or congenital: hypertrophic cardiomyopathy (HCM), arrhythmogenic cardiomyopathy including arrhythmogenic right ventricular cardiomyopathy (ARVC), the inherited channelopathies such as long QT and Brugada syndromes, ventricular pre-excitation, the aortic risk of Marfan syndrome, and coronary artery anomalies. In masters athletes, acquired coronary artery disease becomes the dominant concern, and cardiovascular risk assessment matters more than the inherited conditions. Screening usually combines three things: a health questionnaire covering personal and family history, a physical examination, and a 12-lead electrocardiogram (ECG).
The central difficulty, and the reason this is a topic in its own right, is that the athletic heart adapts to training in ways that show up on the ECG and can look abnormal to the untrained eye. Modern interpretation criteria exist to separate these normal adaptations from the patterns that signal disease, so that healthy athletes are not wrongly disqualified and genuine conditions are not missed. For the sport and exercise medicine (SEM) doctor and the wider musculoskeletal (MSK) team, this means knowing the screening pathway, recognising the red flags, understanding the international criteria for athlete ECG interpretation, and knowing when to refer to sports cardiology or an inherited cardiac conditions service.
Sign up to get full access to 10 topics of your choice, including all sections, clinical pearls, and exam tips.
Sign up free10 free topics included with your account. Full access from £24.17/month.
Sections included with full access